title: Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.
abstract: Cholesterol 7α-hydroxylase (CYP7A1) is the initiating and rate-limiting enzyme in the neutral pathway that converts cholesterol to primary bile acids (BA). CYP7A1-deficient (Cyp7a1(-/-)) mice have a depleted BA pool, diminished intestinal cholesterol absorption, accelerated fecal sterol loss, and increased intestinal cholesterol synthesis. To determine the molecular and physiological effects of restoring the BA pool in this model, adult female Cyp7a1(-/-) mice and matching Cyp7a1(+/+) controls were fed diets containing cholic acid (CA) at modest levels [0.015, 0.030, and 0.060% (wt/wt)] for 15-18 days. A level of just 0.03% provided a CA intake of ~12 μmol (4.8 mg) per day per 100 g body wt and was sufficient in the Cyp7a1(-/-) mice to normalize BA pool size, fecal BA excretion, fractional cholesterol absorption, and fecal sterol excretion but caused a significant rise in the cholesterol concentration in the small intestine and liver, as well as a marked inhibition of cholesterol synthesis in these organs. In parallel with these metabolic changes, there were marked shifts in intestinal and hepatic expression levels for many target genes of the BA sensor farnesoid X receptor, as well as genes involved in cholesterol transport, especially ATP-binding cassette (ABC) transporter A1 (ABCA1) and ABCG8. In Cyp7a1(+/+) mice, this level of CA supplementation did not significantly disrupt BA or cholesterol metabolism, except for an increase in fecal BA excretion and marginal changes in mRNA expression for some BA synthetic enzymes. These findings underscore the importance of using moderate dietary BA levels in studies with animal models.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, TX 75390-9151, USA.
authors.forename: Ryan D
authors.initials: RD
authors.lastname: Jones
authors.forename: Joyce J
authors.initials: JJ
authors.lastname: Repa
authors.forename: David W
authors.initials: DW
authors.lastname: Russell
authors.forename: John M
authors.initials: JM
authors.lastname: Dietschy
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Turley
mesh_terms: D064286:ATP Binding Cassette Transporter 1; D000071019:ATP Binding Cassette Transporter, Subfamily G, Member 8; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D002790:Cholesterol 7-alpha-Hydroxylase / Q000235:genetics / Q000378:metabolism*; D019826:Cholic Acid / Q000008:administration & dosage*; D004032:Diet; D005243:Feces / Q000737:chemistry; D005260:Female; D007408:Intestinal Absorption / Q000502:physiology; D007421:Intestine, Small / Q000737:chemistry / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D051379:Mice; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D013261:Sterols / Q000032:analysis; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D064286:ATP Binding Cassette Transporter 1; D000071019:ATP Binding Cassette Transporter, Subfamily G, Member 8; D018528:ATP-Binding Cassette Transporters; D001647:Bile Acids and Salts; D002784:Cholesterol; D002790:Cholesterol 7-alpha-Hydroxylase; D019826:Cholic Acid; D008074:Lipoproteins; D018160:Receptors, Cytoplasmic and Nuclear; D013261:Sterols; D000099150:Receptor, Farnesoid X-Activated; C462601:ABCG8 protein, mouse; C502772:Cyp7a1 protein, mouse